Clinical Trial Update: Marijuana for HIV-Related Peripheral Neuropathy [Phase 1, Phase 2]

View source ↗

Summary

This update describes a completed Phase 1/2 clinical trial evaluating cannabis (marijuana) for HIV-related peripheral neuropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Peripheral Neuropathy

Drugs mentioned

• Cannabis (Marijuana) (Cannabis)

Snippet

Sponsor: Center for Medicinal Cannabis Research | Conditions: Peripheral Nervous System Diseases, HIV Infections | Phase 1, Phase 2 | Status: COMPLETED